In their new Forefront article, Rick Bright, Steve Brozak, and Richard Marfuggi MD of Bright Global Health and @WBBsec argue that it is not inevitable that H5N1 will develop into a pandemic -- if we act now. bit.ly/4e1DDnI

WBB Research Institute has just published in Health Affairs Forefront: How Policymakers Can Act Now To Prevent An Avian Influenza Pandemic, defining the threat of H5N1 and how to prepare for it. | Health Affairs Rick Bright healthaffairs.org/content/forefr…

As the UN's High-Level Meeting on #AntimicrobialResistance approaches, it's time to rethink our reliance on traditional blood cultures for diagnosing infections.We need to change our diagnostic approach in the fight against AMR #GlobalHealth Rick Bright thelancet.com/journals/lance…

Antimicrobial resistance threatens modern medicine, and the musical #Lifeline brings this crisis to life. Check out this Forbes article for insights on how art and innovation are raising awareness. Lifeline, A Musical That Raises The Alarm On #AMR Forbes forbes.com/sites/stephenb…

What is next for US healthcare? NYT explores how Robert F. Kennedy Jr. a known critic of Big Pharma and regulators, is set to gain new influence. #Healthcare #RFKjr nytimes.com/2024/11/06/us/…

Is RFK Jr. the answer for U.S. healthcare reform? Dr. Brozak’s Forbes article outlines five key signs that indicate possible major changes under RFK Jr.'s influence. #HealthcareReform #Policy forbes.com/sites/stephenb…

Wall Street analyst WBB Securities argues RFK may be "just what the doctor ordered" to improve America's ailing health care system. forbes.com/sites/stephenb…

President Biden’s President Donald J. Trump healthcare initiatives have under-delivered on their promises. Dr. Steve Brozak’s latest article in Forbes describes "Biden’s 2024 Healthcare Legacy: Was It A Failure Of More Than Messaging?" via Forbes forbes.com/sites/stephenb…

A Biotech Showcase panel convened to discuss the threat of H5N1 after the announcement of the first confirmed human case of bird flu. Only through innovative strategies will the threats of infections by H5N1 and other pathogens be effectively addressed forbes.com/sites/stephenb…

What will new tariffs mean for drug prices & availability? In his latest Forbes piece, WBB Securities’ President Dr. Steve Brozak explores what’s ahead for pharma & the supply chain. Read more: Forbes forbes.com/sites/stephenb… #DrugPricing #Tariffs #Pharma #Healthcare

Tariffs on pharmaceuticals could reshape the industry. In his latest Forbes article, Dr. Steve Brozak examines how the U.S. dodged a bullet—for now. But can domestic manufacturing step up? Read more: forbes.com/sites/stephenb… #Pharma #Biotech #Healthcare #DrugShortages #Forbes

President Donald Trump – Will He Become The Drug Price Equalizer? via Forbes by Dr. Steve Brozak, WBB Sec. – Why US drugs are the world’s costliest and how Most Favored Nation will affect the pharma industry. forbes.com/sites/stephenb…

🎉 💬 We’re hosting our 50th complimentary #VirtualSalon w/a timely discussion on CD19 CAR-T therapies & their impact since U.S. FDA approval. I would love for you to join us on May 28, from 11:00 AM – 12:00 PM ET. 👉 Complimentary registration: bit.ly/3Ed22d5

Seven years after the FDA's first approval, what have we learned about #CellTherapy and #GeneTherapy? Join the conversation at the Demy Colton Virtual Salon 🔗 conference.demy-colton.com/seven-years-af… #Biotech #FDA #Innovation #LifeSciences #WBB

WBB Securities acted as sole placement agent in #FELIQSCorp’s $9M Series A to advance FLQ-101, a novel treatment to prevent blindness in premature infants. #Biotech #ROP 🔗 feliqs.reportablenews.com/pr/feliqs-anno…

Dr. Brozak describes why it’s critical to understand the role that Medicaid and Medicaid State-directed payments (SDPs) play in the survival of what are known as Safety Net Hospitals and the entire US Healthcare System. Via Forbes forbes.com/sites/stephenb…